Getachew Ruth, Lee Sunghoon I, Kimball Jon A, Yew Andrew Y, Lu Derek S, Li Charles H, Garst Jordan H, Ghalehsari Nima, Paak Brian H, Razaghy Mehrdad, Espinal Marie, Ostowari Arsha, Ghavamrezaii Amir A, Pourtaheri Sahar, Wu Irene, Sarrafzadeh Majid, Lu Daniel C
Neuroplasticity and Repair Laboratory, UCLA, Los Angeles, USA.
J Neuroeng Rehabil. 2014 Aug 13;11:121. doi: 10.1186/1743-0003-11-121.
The current methods of assessing motor function rely primarily on the clinician's judgment of the patient's physical examination and the patient's self-administered surveys. Recently, computerized handgrip tools have been designed as an objective method to quantify upper-extremity motor function. This pilot study explores the use of the MediSens handgrip as a potential clinical tool for objectively assessing the motor function of the hand.
Eleven patients with cervical spondylotic myelopathy (CSM) were followed for three months. Eighteen age-matched healthy participants were followed for two months. The neuromotor function and the patient-perceived motor function of these patients were assessed with the MediSens device and the Oswestry Disability Index respectively. The MediSens device utilized a target tracking test to investigate the neuromotor capacity of the participants. The mean absolute error (MAE) between the target curve and the curve tracing achieved by the participants was used as the assessment metric. The patients' adjusted MediSens MAE scores were then compared to the controls. The CSM patients were further classified as either "functional" or "nonfunctional" in order to validate the system's responsiveness. Finally, the correlation between the MediSens MAE score and the ODI score was investigated.
The control participants had lower MediSens MAE scores of 8.09%±1.60%, while the cervical spinal disorder patients had greater MediSens MAE scores of 11.24%±6.29%. Following surgery, the functional CSM patients had an average MediSens MAE score of 7.13%±1.60%, while the nonfunctional CSM patients had an average score of 12.41%±6.32%. The MediSens MAE and the ODI scores showed a statistically significant correlation (r=-0.341, p<1.14×10⁻⁵). A Bland-Altman plot was then used to validate the agreement between the two scores. Furthermore, the percentage improvement of the the two scores after receiving the surgical intervention showed a significant correlation (r=-0.723, p<0.04).
The MediSens handgrip device is capable of identifying patients with impaired motor function of the hand. The MediSens handgrip scores correlate with the ODI scores and may serve as an objective alternative for assessing motor function of the hand.
目前评估运动功能的方法主要依赖临床医生对患者体格检查的判断以及患者的自我调查。最近,计算机化握力工具被设计为一种量化上肢运动功能的客观方法。这项初步研究探索了使用MediSens握力工具作为客观评估手部运动功能的潜在临床工具。
对11例脊髓型颈椎病(CSM)患者进行了3个月的随访。对18名年龄匹配的健康参与者进行了2个月的随访。分别使用MediSens设备和奥斯威斯利功能障碍指数评估这些患者的神经运动功能和患者自我感知的运动功能。MediSens设备利用目标跟踪测试来研究参与者的神经运动能力。将目标曲线与参与者绘制的曲线之间的平均绝对误差(MAE)用作评估指标。然后将患者调整后的MediSens MAE评分与对照组进行比较。为了验证该系统的反应性,将CSM患者进一步分为“功能型”或“非功能型”。最后,研究了MediSens MAE评分与ODI评分之间的相关性。
对照组参与者的MediSens MAE评分为8.09%±1.60%,较低;而颈椎疾病患者的MediSens MAE评分为11.24%±6.29%,较高。手术后,功能型CSM患者的平均MediSens MAE评分为7.13%±1.60%,而非功能型CSM患者的平均评分为12.41%±6.32%。MediSens MAE评分与ODI评分显示出统计学上的显著相关性(r=-0.341,p<1.14×10⁻⁵)。然后使用布兰德-奥特曼图来验证两个评分之间的一致性。此外,接受手术干预后两个评分的改善百分比显示出显著相关性(r=-0.723,p<0.04)。
MediSens握力设备能够识别手部运动功能受损的患者。MediSens握力评分与ODI评分相关,可作为评估手部运动功能的客观替代方法。